U.S. Dermatology Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices, Treatment Devices), By Application, By End-use (Hospitals, Clinics), By Region,- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033

U.S. Dermatology Devices Market Size and Trends
The U.S. dermatology devices market size was exhibited at USD 6.15 billion in 2023 and is projected to hit around USD 20.15 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2024 to 2033.

U.S. Dermatology Devices Market Key Takeaways:

The treatment devices segment led the market with the largest revenue share of 79.5%in 2023.
The diagnostic devices segment accounted for a considerable market share in 2023.
Based on end-use, the hospital segment led the market with the largest revenue share of 53.18% in 2023
The clinics segment is projected to witness at the fastest CAGR over the forecast period.
Based on application, the treatment segment accounted for the largest market share in 2023

Market Overview
The U.S. dermatology devices market is a vibrant and rapidly evolving segment of the medical devices industry, driven by both clinical necessity and aesthetic demand. Dermatology devices encompass a wide range of technologies used for diagnosing and treating conditions of the skin, hair, and nails. From skin cancer screening and acne management to laser-assisted wrinkle removal and body contouring, these devices serve an expanding pool of medical and cosmetic needs across varied patient demographics.
In the U.S., dermatology has grown beyond its traditional role of treating pathologies to encompass advanced cosmetic procedures, particularly non-invasive and minimally invasive treatments. According to the American Academy of Dermatology, over 50 million Americans experience skin diseases annually, with skin cancer being the most common. This increasing disease burden, coupled with heightened consumer demand for aesthetic enhancement, is creating a dual-purpose marketplace for diagnostic and therapeutic devices.
Technological innovation is also fueling market transformation. Device manufacturers are introducing advanced lasers, AI-integrated imaging systems, and multi-functional platforms capable of handling both diagnostic evaluations and treatment regimens. Moreover, with the rising popularity of teledermatology, portable imaging and diagnostic tools are being used in remote consultations and primary care settings. Cosmetic dermatology clinics are flourishing, supported by social media trends, celebrity influence, and a shift in consumer preferences toward self-enhancement and wellness. Altogether, the U.S. dermatology devices market is poised for sustained growth, underpinned by clinical relevance, patient awareness, and technological advancement.
Major Trends in the Market

Rise in Non-Invasive Aesthetic Procedures: There is increasing demand for laser-based treatments, body contouring, and skin resurfacing techniques that require no downtime.

Integration of AI in Skin Diagnostics: Dermatologists are adopting artificial intelligence to aid in mole analysis, lesion detection, and early-stage skin cancer diagnosis.

Growing Popularity of Portable Devices: Clinics and dermatologists are utilizing compact, wireless diagnostic and treatment devices that enhance mobility and point-of-care flexibility.

Adoption of Multimodal Devices: Platforms capable of handling multiple functions, such as combining light therapy and cryotherapy, are gaining preference to reduce space and cost.

Patient-Centric Cosmetic Dermatology: Rising demand for personalized skincare solutions is driving the need for devices that can tailor treatments based on skin type and concerns.

Increase in Men’s Dermatology Treatments: Male consumers are increasingly participating in hair removal, acne treatment, and wrinkle reduction procedures, expanding the patient base.

Medical Tourism Within the U.S.: Patients travel domestically to high-end clinics known for dermatological excellence, particularly in regions like the West Coast and Florida.

Growth of Physician-Owned Aesthetic Clinics: Dermatologists and plastic surgeons are investing in in-house device platforms to offer one-stop diagnostic and cosmetic services.

Report Scope of U.S. Dermatology Devices Market

Report Coverage
Details

Market Size in 2024
USD 6.92 Billion

Market Size by 2033
USD 20.15 Billion

Growth Rate From 2024 to 2033
CAGR of 12.6%

Base Year
2023

Forecast Period
2024-2033

Segments Covered
Product, Application, End-use, Region

Market Analysis (Terms Used)
Value (US$ Million/Billion) or (Volume/Units)

Regional Scope
U.S.

Key Companies Profiled
Cutera, Inc.; Genesis Biosystems, Inc.; Candela Medical Corporation; Bausch Health Companies Inc.; DermLite.; Cynosure Inc.; Avita Medical, Inc,; Skin Science Solutions, Inc.; Canfield Scientific, Inc.

Market Driver: Rising Skin Disease Burden and Aesthetic Awareness
The most significant driver of the U.S. dermatology devices market is the convergence of rising dermatological disorders and growing aesthetic consciousness. Skin conditions like psoriasis, acne, rosacea, eczema, vitiligo, and melanoma are increasingly common across all age groups. The CDC reports that skin cancer affects over 5 million Americans annually, and early detection can dramatically improve survival rates. Diagnostic tools such as dermatoscopes and digital imaging systems are critical in screening and monitoring such cases.
Simultaneously, Americans are spending more on cosmetic dermatology to combat aging, sun damage, and lifestyle-induced skin imperfections. Laser therapy, light-based devices, and microdermabrasion are routinely used for wrinkle reduction, scar management, and skin tone correction. The American Society for Dermatologic Surgery (ASDS) reports that cosmetic procedures increased by over 60% in the past five years. This dual demand for medical and cosmetic intervention is expanding device utilization across a spectrum of providers, from hospital departments to boutique aesthetic clinics.
Market Restraint: High Equipment Costs and Limited Reimbursement
Despite promising growth, the U.S. dermatology devices market faces a restraint in the form of high initial investment and limited insurance coverage for certain procedures. Advanced dermatology devices such as fractional lasers, RF microneedling platforms, and AI-powered imaging systems can cost between $30,000 and $250,000 per unit. For independent clinics and dermatologists, this represents a significant financial burden, especially considering device maintenance, consumables, and staff training.
Furthermore, insurance reimbursement is often limited to medically necessary procedures—such as skin cancer biopsies or treatment for chronic skin conditions. Most aesthetic procedures, including body contouring, tattoo removal, and wrinkle reduction, are considered elective and thus not reimbursed. This restricts access to patients who can afford out-of-pocket payments and creates a competitive disadvantage for providers in lower-income areas. While technology democratization and leasing models are easing entry barriers, affordability and insurance constraints remain persistent issues.
Market Opportunity: Expansion of Teledermatology and At-Home Devices
One of the most compelling opportunities in the U.S. dermatology devices market lies in the expansion of teledermatology and at-home device use. The COVID-19 pandemic dramatically accelerated the adoption of remote consultations, and dermatology proved particularly adaptable due to its visual nature. As virtual care becomes a standard part of the healthcare model, portable diagnostic devices, including smartphone-attachable dermatoscopes and digital mole scanners, are being integrated into telehealth platforms.
Simultaneously, consumer-facing devices for acne treatment, hair removal, and light therapy are gaining traction in the at-home skincare market. Brands like Foreo, Tria Beauty, and Silk’n offer FDA-cleared devices for laser hair removal and LED-based acne therapy. Dermatologists are also recommending or retailing at-home devices to supplement in-clinic treatments. As remote care and consumer empowerment become central to dermatological care models, the convergence of telemedicine and self-care technology presents a long-term growth frontier.
U.S. Dermatology Devices Market By Product Insights
Treatment devices dominated the U.S. dermatology devices market, driven by their wide application across cosmetic and therapeutic domains. Within this category, lasers are the most extensively used tools for procedures such as hair removal, tattoo removal, vascular lesion treatment, and skin resurfacing. Fractional and ablative lasers provide high precision and minimal recovery times, making them attractive for both providers and patients. Likewise, light therapy devices, including intense pulsed light (IPL) systems, are highly popular for acne, pigmentation, and rejuvenation. Electrosurgical units are also vital for mole removal and wart ablation, while liposuction and cryotherapy devices are key in body contouring and lesion treatment, respectively.
Diagnostic devices are growing at a rapid pace, especially as skin cancer awareness spreads. Dermatoscopes remain indispensable tools for dermatologists, enabling magnified visualization of skin lesions and aiding in early cancer detection. Advanced imaging devices, including 3D mapping and AI-assisted scanners, are increasingly being deployed in large dermatology practices and academic medical centers. Additionally, biopsy devices are evolving with less invasive designs and greater sampling precision. As teledermatology and AI integration expand, diagnostic tools will continue to play a pivotal role in the early and accurate assessment of skin conditions.
U.S. Dermatology Devices Market By End-use Insights
Clinics remain the dominant end-use segment, as specialized dermatology and aesthetic centers are the primary adopters of dermatology devices. Clinics offer flexibility, personalized treatments, and the ability to cater to both cosmetic and medical dermatology. A growing number of dermatologists are opening physician-owned practices equipped with advanced device portfolios to offer procedures ranging from acne treatment to full-body skin assessments. Clinics also benefit from shorter patient wait times and customized care plans, leading to higher patient satisfaction and repeat visits.

Hospitals are increasingly incorporating dermatology devices, particularly for skin cancer diagnostics, wound management, and severe dermatological conditions. Larger institutions and academic centers invest in high-end diagnostic tools and laser equipment for complex cases. However, consumer clinics and medispas are emerging as the fastest-growing segment due to the surge in demand for aesthetic dermatology. These centers focus on volume-based services and typically operate multiple devices in the same facility. Their business model supports high throughput and targets a younger, trend-conscious demographic.
U.S. Dermatology Devices Market By Application Insights
Treatment applications dominate the market, with a particularly high volume of procedures for hair removal and skin rejuvenation. These applications account for a significant portion of both clinical and consumer spending. Dermatologists and medical spas offer laser-based treatments that are safe, quick, and effective for long-term hair reduction. Skin rejuvenation, which includes anti-aging treatments, scar reduction, and texture correction, is another high-demand area benefiting from both lasers and microdermabrasion devices. Increasing social acceptance of cosmetic procedures and innovations in non-invasive technologies are further expanding this segment.
Body contouring and fat removal represent the fastest-growing application area, buoyed by demand for non-surgical aesthetic body reshaping. Technologies such as cryolipolysis, radiofrequency, and laser-assisted lipolysis are offering patients visible results without surgery or downtime. These treatments appeal to both men and women, particularly in metro regions where aesthetics and fitness trends are prominent. Simultaneously, vascular and pigmented lesion removal is gaining momentum as patients seek solutions for rosacea, sun spots, and melasma. The versatility of dermatology devices to treat diverse cosmetic concerns is a major factor in the rising procedural volume.
Country-Level Analysis
The U.S. dermatology devices market reflects regional diversity in terms of patient demographics, clinic density, and aesthetic awareness. The West region, especially California, is the largest and most mature market. Cities like Los Angeles, San Diego, and San Francisco are epicenters of cosmetic dermatology, driven by entertainment culture, affluence, and a proactive approach to skincare. These areas have high device penetration, robust provider networks, and early adoption of new technologies. Additionally, dermatology startups and tech companies often launch in the West due to the presence of venture capital and innovation ecosystems.
The Southwest region, particularly Texas and Arizona, is experiencing the fastest growth. This can be attributed to increasing population, higher sun exposure leading to more skin-related concerns, and the expansion of outpatient aesthetic services. Texas has a thriving network of aesthetic centers in cities like Houston, Dallas, and Austin, catering to both medical and cosmetic needs. The region's large Hispanic population also presents unique dermatological care needs, spurring demand for inclusive, skin-type-specific devices. With a mix of affordability and growing sophistication, the Southwest is set to lead future growth trajectories.
Some of the prominent players in the U.S. dermatology devices market include:

Cutera, Inc.
Genesis Biosystems, Inc.
Cytrellis, Inc.
Candela Medical Corporation
Bausch Health Companies Inc.
DermLite.
Cynosure Inc.
Avita Medical, Inc,
Skin Science Solutions, Inc.
Canfield Scientific, Inc.

Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. dermatology devices market
Product

Diagnostic Devices

Dermatoscopes
Microscopes
Other Imaging Devices
Biopsy Devices

Treatment Devices

Light Therapy Devices
Lasers
Electrosurgical Equipment
Liposuction Devices
Microdermabrasion Devices
Cryotherapy Devices

Application

Diagnostics Application

Skin Cancer Diagnosis
Other

Treatment Application

Hair Removal
Skin Rejuvenation
Acne, Psoriasis, and Tattoo Removal
Wrinkle Removal and Skin Resurfacing
Body Contouring and Fat Removal
Cellulite Reduction
Vascular and Pigmented Lesion Removal
Others

End-use

Hospitals
Clinics
Others

Regional

West
Midwest
Northeast
Southwest
Southeast


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Dermatology Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Dermatology Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Dermatology Devices Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. U.S. Dermatology Devices Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Diagnostic devices
4.4.1.1. Market estimates and forecasts 2021 to 2033
4.4.1.1.1. Dermatoscope
4.4.1.1.1.1. Market estimates and forecasts, 2021 to 2033
4.4.1.1.2. Microscopes
4.4.1.1.2.1. Market estimates and forecasts, 2021 to 2033
4.4.1.1.3. Other Imaging Devices
4.4.1.1.3.1. Market estimates and forecasts, 2021 to 2033
4.4.1.1.4. Biopsy Devices
4.4.1.1.4.1. Market estimates and forecasts, 2021 to 2033
4.4.2. Treatment devices
4.4.2.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.1. Light Therapy Devices
4.4.2.1.1.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.2. Lasers
4.4.2.1.2.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.3. Electrosurgical Equipment
4.4.2.1.3.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.4. Liposuction Devices
4.4.2.1.4.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.5. Microdermabrasion Devices
4.4.2.1.5.1. Market estimates and forecasts, 2021 to 2033
4.4.2.1.6. Cryotherapy Devices
4.4.2.1.6.1. Market estimates and forecasts, 2021 to 2033
Chapter 5. U.S. Dermatology Devices Market: Region Estimates & Trend Analysis
5.1. Regional Market Share, 2024 & 2033
5.2. U.S. Dermatology Devices Market by Region Outlook
5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the Following
5.3.1. West
5.3.1.1. Market estimates and forecasts 2021 to 2033
5.3.2. Midwest
5.3.2.1. Market estimates and forecasts 2021 to 2033
5.3.3. Northeast
5.3.3.1. Market estimates and forecasts 2021 to 2033
5.3.4. Southwest
5.3.4.1. Market estimates and forecasts 2021 to 2033
5.3.5. Southeast
5.3.5.1. Market estimates and forecasts 2021 to 2033
Chapter 6. U.S. Dermatology Devices Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. U.S. Dermatology Devices Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Diagnostics Application
6.4.1.1. Market estimates and forecasts, 2021 to 2033
6.4.1.1.1. Skin Cancer Diagnosis
6.4.1.1.1.1. Market estimates and forecasts, 2021 to 2033
6.4.1.1.2. Other
6.4.1.1.2.1. Market estimates and forecasts, 2021 to 2033
6.4.2. Treatment application
6.4.2.1. Treatment application market estimates and forecasts, 2021 to 2033
6.4.2.1.1. Hair Removal
6.4.2.1.1.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.2. Skin Rejuvenation
6.4.2.1.2.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.3. Acne, Psoriasis, and Tattoo Removal
6.4.2.1.3.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.4. Wrinkle Removal and Skin Resurfacing
6.4.2.1.4.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.5. Body Contouring and Fat Removal
6.4.2.1.5.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.6. Vascular and Pigmented Lesion Removal
6.4.2.1.6.1. Market estimates and forecasts, 2021 to 2033
6.4.2.1.7. Others
6.4.2.1.7.1. Market estimates and forecasts, 2021 to 2033
Chapter 7. U.S. Dermatology Devices Market: End-use Estimates & Trend Analysis
7.1. End-use Market Share, 2024 & 2033
7.2. Segment Dashboard
7.3. U.S. Dermatology Devices Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.4.1. Hospitals
7.4.1.1. Market estimates and forecasts, 2021 to 2033
7.4.2. Clinics
7.4.2.1. Market estimates and forecasts, 2021 to 2033
7.4.3. Others
7.4.3.1. Market estimates and forecasts, 2021 to 2033
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Company Profiles
8.3.1. Cutera, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Genesis Biosystems, Inc.
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Cytrellis, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Candela Medical Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Bausch Health Companies Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. DermLite.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Cynosure Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Avita Medical, Inc,
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Skin Science Solutions, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Canfield Scientific, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings